CliffBio
small molecule

DEXMETHYLPHENIDATE HYDROCHLORIDE

DEXMETHYLPHENIDATE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyTris. →See this company's full patent-cliff portfolio

Drug detail

Brand nameDEXMETHYLPHENIDATE HYDROCHLORIDE
Active ingredientDEXMETHYLPHENIDATE HYDROCHLORIDE
Strength5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2016
Marketing statusRX

More from Tris.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DEXMETHYLPHENIDATE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio